Feasibility of combining tDCS with TMS-EEG to probe neuroplasticity in post-stroke aphasia
Neuropsychological Rehabilitation · 09.08.2026 · 36 (7) · 1464-1494
DOI: 10.1080/09602011.2025.2603397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychological Rehabilitation, online erschienen am 16.12.2025. Verfasst von Mădălina Bucur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mind/Brain Sciences (CIMeC), University of Trento, Trento, Italy. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation, Stroke, Electroencephalography, Neuronal Plasticity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Autonomous Province of Trento, Fondazione Cassa di Risparmio di Trento e Rovereto, Municipality of Trento.
Themen: Schlaganfall
Abstract (Originalsprache)
Increasing evidence suggests that transcranial direct current stimulation (tDCS) can enhance language outcomes in people with post-stroke aphasia. However, the neurophysiological mechanisms underlying these behavioral improvements remain insufficiently characterized.This crossover feasibility study examined the clinical and technical viability of integrating transcranial magnetic stimulation with electroencephalography (TMS-EEG) to characterize cortical excitability and network dynamics before and after real and sham tDCS in individuals with chronic post-stroke non-fluent aphasia.Eight participants were enrolled; four completed the full protocol, while four discontinued due to scheduling or technical constraints. The completers underwent eight weeks of anodal tDCS and language exercises. They tolerated the combined procedures well, with full adherence, no adverse events, and good-quality TMS-EEG recordings, confirming the protocol's feasibility.Cortical responses were quantified using global and local mean field power (GMFP, LMFP) and a regional complexity index. Behaviorally, modest language improvements were observed in two participants with Broca's aphasia. Neurophysiologically, heterogeneous modulations of cortical reactivity were observed across cases.These findings indicate that this multimodal protocol can be practically and safely implemented, with no adverse effects observed, while also underscoring logistical, technical, and clinical considerations for larger-scale studies designed to elucidate the neurophysiological mechanisms supporting tDCS-driven language recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Mind/Brain Sciences (CIMeC), University of Trento, Trento, Italy.
- Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
- CeRiN - Neurocognitive Rehabilitation Center, University of Trento, Rovereto, Italy.
- Department of Psychology, University of Milano-Bicocca, Milan, Italy.
- IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
ORCID-Profile: Mădălina Bucur
Förderung
- Autonomous Province of Trento
- Fondazione Cassa di Risparmio di Trento e Rovereto
- Municipality of Trento
- Italian Ministry for Universities and Research
Zitieren
APA
Bucur, M., Zambon, F., Pisoni, A., Baruzzo, E., Casarotto, S., Rosanova, M., & Papagno, C. (2026). Feasibility of combining tDCS with TMS-EEG to probe neuroplasticity in post-stroke aphasia. Neuropsychological Rehabilitation, 36(7), 1464-1494. https://doi.org/10.1080/09602011.2025.2603397
Vancouver
Bucur M, Zambon F, Pisoni A, Baruzzo E, Casarotto S, Rosanova M, et al. Feasibility of combining tDCS with TMS-EEG to probe neuroplasticity in post-stroke aphasia. Neuropsychological Rehabilitation. 2026;36(7):1464-1494. doi:10.1080/09602011.2025.2603397
BibTeX
@article{Bucur2026,
author = {Bucur, Mădălina and Zambon, Francesca and Pisoni, Alberto and Baruzzo, Elena and Casarotto, Silvia and Rosanova, Mario and Papagno, Costanza},
title = {Feasibility of combining tDCS with TMS-EEG to probe neuroplasticity in post-stroke aphasia},
journal = {Neuropsychological Rehabilitation},
year = {2026},
volume = {36},
number = {7},
pages = {1464--1494},
doi = {10.1080/09602011.2025.2603397}
}
EUVIMED